Towards a Non-Opioid Pain Control Pathway and Best Practices for the Head, Neck, and Thyroid Patient

Presented by Gregory W. Randolph MD, FEBS (Endocrine), FACS, FACE; Tiffany V. Wang, MD; Jenny X. Chen, MD
Presented on December 3, 2020

During the webinar, Drs. Randolph, Wang, and Chen of the Massachusetts Eye and Ear Infirmary discussed the upcoming AHNS Endocrine Section Postoperative Opioid Consensus Statement (not yet released), patient screening and pain management planning, and best practices for reducing postoperative opioid needs following otolaryngology surgical procedures.

During the webinar, a live question and answer session with the panelists took place. This recorded webinar is designated for 1 AMA PRA Category 1 Credit™. The webinar is now available on the ACS Learning Management System.

Speakers

Tiffany V. Wang, MD
Resident, PGY4
Massachusetts Eye and Ear/Harvard Otolaryngology Program

Jenny X. Chen, MD
Chief resident, PGY5
Massachusetts Eye and Ear/Harvard Otolaryngology Program

Moderator

Gregory W. Randolph MD, FEBS (Endocrine), FACS, FACE
Professor of Otolaryngology Head and Neck Surgery,
Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology, Harvard Medical School
Director Thyroid/Parathyroid Endocrine Surgical Division, Massachusetts Eye and Ear Infirmary
Member Endocrine Surgical Service, Massachusetts General Hospital
President American Academy of Otolaryngology Head and Neck Surgery 2016-17
American Head and Neck Society, Endocrine Section Chair